Fresenius SE & Co KGaA (FRE) Given a €80.00 Price Target at Warburg Research

Fresenius SE & Co KGaA (FRA:FRE) has been assigned a €80.00 ($95.24) price objective by research analysts at Warburg Research in a report issued on Monday. The firm presently has a “buy” rating on the stock. Warburg Research’s price target points to a potential upside of 18.91% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the company. Morgan Stanley set a €83.00 ($98.81) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Wednesday, October 4th. Citigroup set a €83.00 ($98.81) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Tuesday, October 3rd. Berenberg Bank set a €90.00 ($107.14) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Wednesday, September 20th. Oddo Bhf set a €82.00 ($97.62) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Monday, October 23rd. Finally, Deutsche Bank set a €84.00 ($100.00) price objective on Fresenius SE & Co KGaA and gave the company a “buy” rating in a report on Friday, October 20th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Fresenius SE & Co KGaA has an average rating of “Buy” and an average target price of €78.66 ($93.65).

Fresenius SE & Co KGaA (FRA FRE) opened at €67.28 ($80.10) on Monday. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($71.62) and a 1-year high of €80.00 ($95.24). The firm has a market capitalization of $37,210.00 and a PE ratio of 21.43.

TRADEMARK VIOLATION NOTICE: This article was published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.themarketsdaily.com/2018/01/10/fresenius-se-80-00-price-target-at-warburg-research-2.html.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply